Scientific Sessions

The Scientific Sessions at the International Conference on Cancer Therapeutics are designed to highlight the most advanced research, therapeutic innovations, and future directions shaping next-generation cancer treatment strategies. These sessions cover a broad spectrum of topics including molecular oncology, targeted therapies, immuno-oncology, precision medicine, cancer genomics, biomarker discovery, drug resistance mechanisms, combination therapies, and emerging therapeutic platforms. Each session reflects current global research priorities and evolving clinical needs, offering evidence-based insights with strong translational and real-world relevance. Renowned oncologists, cancer researchers, translational scientists, pharmaceutical experts, academicians, and healthcare professionals from across the world come together to share expertise, innovations, and scientific breakthroughs.

The program features keynote lectures, plenary talks, oral and poster presentations, panel discussions, and interactive scientific forums. These sessions foster interdisciplinary collaboration, encourage knowledge exchange, and promote innovation across cancer research and therapeutic development. Participants gain opportunities to present research, receive expert feedback, explore cutting-edge therapeutic approaches and drug development pipelines, and build meaningful academic, clinical, and industry networks. Designed for researchers, clinicians, academicians, students, and industry professionals, the Scientific Sessions aim to advance precision oncology, therapeutic excellence, and patient-centered cancer care with global impact.

Molecular targets in cancer therapy represent a transformative approach to cancer treatment by focusing on specific genes, proteins, signaling pathways, and cellular mechanisms that drive cancer initiation, progression, and resistance. Unlike conventional chemotherapy, which affects both cancerous and normal cells, molecularly targeted therapies are designed to selectively inhibit cancer-specific abnormalities, thereby improving treatment efficacy while reducing toxicity. This strategy has significantly advanced precision oncology and personalized cancer care Key molecular targets include growth factor receptors such as EGFR, HER2, and VEGFR, which regulate cell proliferation, survival, and angiogenesis. Aberrant activation or overexpression of these receptors is commonly observed in multiple cancers, including breast, lung, and colorectal cancers. Targeting these receptors with monoclonal antibodies or small-molecule inhibitors can effectively block tumor growth and spread. Additionally, intracellular signaling pathways such as PI3K/AKT/mTOR, MAPK, and JAK/STAT play crucial roles in tumor cell survival and resistance, making them important therapeutic targets.

Join us at the International Conference on Cancer Therapeutics by submitting a one-page abstract and contributing to advancements in precision-driven cancer treatment.

Relevant Conferences: World Cancer Congress| Oncology 2026 Conference| Cancer Research and Therapy conferences | Global Oncology summit| Experts Meet on Cancer Research & Therapy meeting| International Conference on Cancer Research and Treatment workshop| International Virtual Conference on Cancer Research and Oncology seminar| International Conference on Cancer Science and Therapy event| International Conference of Global Cancer Consortium congress| Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference| Cancer Science and Therapeutic Innovations meetings| Precision in Clinical Trials Oncology Summit| Molecular Targets in Cancer Therapy seminars

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Precision oncology focuses on tailoring cancer treatment based on the individual genetic and molecular characteristics of a patient’s tumor. By using advanced diagnostic tools such as genomic profiling and biomarker analysis, clinicians can identify actionable mutations and select targeted therapies that improve treatment effectiveness while minimizing side effects. Personalized cancer treatment also guides the use of immunotherapy, chemotherapy, and combination strategies by predicting patient response and resistance. This approach enables more accurate, patient-centered care, leading to improved outcomes, reduced toxicity, and better quality of life.

We invite abstract submissions that highlight novel therapeutic strategies and translational research at the International Conference on Cancer Therapeutics

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Targeted small-molecule cancer therapeutics are designed to selectively inhibit specific molecular pathways and intracellular targets that drive cancer growth, survival, and progression. Unlike traditional chemotherapy, these agents can penetrate cells and directly block oncogenic proteins such as kinases, transcription factors, and signaling molecules, resulting in greater specificity and reduced damage to normal tissues. These therapies have shown significant clinical success in cancers driven by well-defined genetic alterations, including EGFR, BRAF, ALK, and PI3K pathway mutations. Small-molecule inhibitors play a critical role in precision oncology, often used alone or in combination with other treatments to overcome resistance and improve patient outcomes. Continued advancements in drug design and molecular profiling are expanding their impact across a wide range of malignancies.

Present your research at the Cancer Therapeutics Conference by submitting a one-page abstract and engaging with international oncology leaders.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Monoclonal antibodies (mAbs) are highly specific cancer therapeutics designed to recognize and bind to target antigens expressed on cancer cells or within the tumor microenvironment. By blocking growth signals, inducing immune-mediated cell destruction, or inhibiting angiogenesis, monoclonal antibodies have become a cornerstone of targeted cancer therapy. Widely used examples include antibodies targeting HER2, EGFR, VEGF, and immune checkpoints, which have significantly improved outcomes in several cancers. Antibody–drug conjugates (ADCs) represent an advanced evolution of monoclonal antibody therapy. ADCs combine the targeting precision of monoclonal antibodies with the cytotoxic potency of chemotherapy drugs, delivering toxic payloads directly to cancer cells while minimizing systemic toxicity. This targeted delivery enhances therapeutic efficacy and reduces off-target effects. Ongoing innovations in antibody engineering, linker technology, and payload selection continue to expand the clinical potential of mAbs and ADCs in modern oncology.

Researchers, clinicians, and pharmaceutical experts are invited to submit one-page abstracts for presentation at the International Conference on Cancer Therapeutics.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Immunotherapy has revolutionized cancer treatment by harnessing the body’s own immune system to recognize and eliminate cancer cells. Among the most impactful immunotherapeutic approaches are immune checkpoint inhibitors, which target regulatory pathways that normally suppress immune responses. Cancer cells often exploit checkpoints such as programmed cell death protein-1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) to evade immune surveillance. By blocking these inhibitory signals, checkpoint inhibitors restore T-cell activity, enabling a more effective and durable anti-tumor immune response. Immune checkpoint inhibitors have demonstrated remarkable clinical success across a wide range of cancers, including melanoma, lung cancer, renal cell carcinoma, and several hematological malignancies. These therapies can produce long-lasting responses and improved survival in selected patients, particularly when guided by predictive biomarkers such as PD-L1 expression and tumor mutational burden. Ongoing research is focused on overcoming resistance, managing immune-related adverse events, and developing combination strategies to expand the benefits of immunotherapy and deliver more personalized and effective cancer care.

The Cancer Therapeutics Conference welcomes abstract submissions focused on targeted therapies, immuno-oncology, and next-generation cancer treatments.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Cancer vaccines and cellular immunotherapies are innovative treatment strategies designed to stimulate or enhance the immune system’s ability to recognize and destroy cancer cells. Cancer vaccines work by exposing the immune system to tumor-associated or tumor-specific antigens, training it to mount a targeted immune response against cancer cells. These vaccines may be preventive or therapeutic and are being actively explored in cancers such as melanoma, prostate cancer, and hematological malignancies. Advances in neoantigen discovery, mRNA technology, and dendritic cell–based vaccines have significantly improved vaccine specificity and immunogenicity. Cellular immunotherapies, including chimeric antigen receptor (CAR) T-cell therapy, T-cell receptor (TCR) therapy, and tumor-infiltrating lymphocyte (TIL) therapy, involve the modification or expansion of immune cells to enhance their cancer-fighting capabilities. These therapies have shown remarkable success, particularly in certain blood cancers, by enabling immune cells to directly target and eliminate malignant cells. Ongoing research aims to extend the benefits of cellular immunotherapies to solid tumors, improve safety, and develop combination approaches, making them a powerful and evolving component of modern cancer treatment.

Submit your abstract to the Internati onal Conference on Cancer Therapeutics and join global discussions driving innovation in cancer care.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

CAR-T and other advanced cell-based therapies represent a major breakthrough in cancer treatment by genetically engineering a patient’s own immune cells to specifically recognize and destroy cancer cells. Chimeric antigen receptor T-cell (CAR-T) therapy involves modifying T cells to express synthetic receptors that bind to cancer-associated antigens, enabling potent and targeted immune responses. This approach has demonstrated remarkable clinical success in hematological malignancies such as leukemia, lymphoma, and multiple myeloma, offering durable remissions in patients with otherwise treatment-resistant disease. Beyond CAR-T therapy, advanced cell-based approaches such as T-cell receptor (TCR) therapies, tumor-infiltrating lymphocytes (TILs), and natural killer (NK) cell therapies are expanding the scope of cellular immunotherapy. These strategies aim to overcome challenges such as antigen escape, tumor heterogeneity, and toxicity, while improving efficacy in solid tumors. Ongoing innovations in gene editing, manufacturing technologies, and combination regimens continue to refine cell-based therapies, positioning them as a powerful and evolving pillar of precision cancer treatment.

We invite professionals across the oncology spectrum to submit one-page abstracts and contribute to shaping the future of cancer therapeutics.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Gene therapy and genome editing offer transformative approaches to cancer treatment by directly targeting the genetic abnormalities that drive tumor development and progression. Gene therapy strategies involve introducing, silencing, or modifying genes within cancer cells or immune cells to restore normal cellular function, enhance anti-tumor immunity, or sensitize tumors to existing treatments. Approaches such as viral and non-viral gene delivery systems are being explored to correct oncogenic mutations, activate tumor suppressor genes, and deliver therapeutic genes that induce cancer cell death. Genome editing technologies, particularly CRISPR-Cas systems, have further advanced the precision of cancer therapy by enabling targeted modification of specific DNA sequences. These tools are being used to engineer immune cells for enhanced cancer recognition, disrupt genes responsible for drug resistance, and study cancer biology at an unprecedented level of accuracy. While challenges related to safety, delivery, and off-target effects remain, ongoing research and clinical trials continue to refine gene-based strategies, highlighting their growing potential in personalized and next-generation cancer therapeutics.

The Cancer Therapeutics Conference invites abstracts that reflect cutting-edge science, clinical excellence, and translational impact in cancer treatment.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Epigenetic targets and chromatin remodeling play a crucial role in cancer development by regulating gene expression without altering the underlying DNA sequence. Epigenetic mechanisms such as DNA methylation, histone modifications, and chromatin structure changes can lead to the activation of oncogenes or silencing of tumor suppressor genes. Targeting these reversible alterations has emerged as an important therapeutic strategy, offering the potential to reprogram cancer cells and restore normal cellular function. Drugs targeting epigenetic regulators, including DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), have already shown clinical benefit in certain hematological malignancies. Advances in understanding chromatin remodeling complexes and epigenetic writers, readers, and erasers have expanded the range of potential therapeutic targets. Inhibitors of bromodomain and extra-terminal (BET) proteins, histone methyltransferases, and chromatin remodeling enzymes are being actively investigated in solid and hematologic cancers. Epigenetic therapies are also being explored in combination with immunotherapy, targeted therapy, and chemotherapy to overcome drug resistance and enhance treatment response. Continued research into epigenetic regulation promises to unlock new opportunities for precision and personalized cancer treatment.

Share your research findings by submitting a one-page abstract to the International Conference on Cancer Therapeutics and connect with a global oncology network

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Signal transduction pathways are critical cellular communication networks that regulate essential processes such as cell growth, differentiation, survival, and apoptosis. In cancer, these pathways are often dysregulated due to genetic mutations, overexpression of receptors, or abnormal activation of downstream signaling proteins, leading to uncontrolled cell proliferation and tumor progression. Key pathways commonly altered in cancer include the MAPK/ERK, PI3K/AKT/mTOR, JAK/STAT, Wnt/β-catenin, and Notch signaling pathways. Aberrations in these pathways enable cancer cells to evade growth control, resist cell death, and adapt to hostile environments. Understanding signal transduction abnormalities has enabled the development of targeted therapies that specifically inhibit oncogenic signaling components. Small-molecule inhibitors and monoclonal antibodies targeting receptors, kinases, and downstream effectors have shown significant clinical benefit across multiple cancer types. Ongoing research focuses on overcoming resistance mechanisms, identifying predictive biomarkers, and designing combination therapies to achieve sustained pathway suppression. Advances in targeting signal transduction pathways continue to drive progress in precision oncology and improve outcomes.

Oncologists and cancer researchers are encouraged to submit one-page abstracts and engage in meaningful scientific exchange at the Cancer Therapeutics Conference.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

cancer patients.

The tumor microenvironment (TME) consists of a complex network of cancer cells, immune cells, stromal cells, blood vessels, extracellular matrix, and signaling molecules that collectively influence tumor growth and treatment response. Interactions within the TME can promote cancer progression by supporting angiogenesis, immune evasion, and metabolic adaptation. These dynamic interactions often protect tumor cells from therapeutic stress, reducing the effectiveness of chemotherapy, targeted therapy, and immunotherapy. Therapeutic resistance frequently arises as tumor cells adapt to or exploit the microenvironment through altered signaling, immune suppression, and physical barriers to drug delivery. Factors such as hypoxia, cancer-associated fibroblasts, and immunosuppressive cells contribute to both intrinsic and acquired resistance. Understanding the role of the TME in resistance has led to the development of novel strategies aimed at targeting the microenvironment, reprogramming immune responses, and combining therapies to overcome resistance and improve long-term treatment outcomes.

The International Conference on Cancer Therapeutics invites the submission of abstracts highlighting breakthrough discoveries and clinical innovations in oncology.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Drug resistance in cancer is a major challenge that limits the long-term effectiveness of many anticancer therapies. Resistance can be intrinsic, where tumors are inherently insensitive to treatment, or acquired, developing after initial response. Key mechanisms include genetic mutations that alter drug targets, activation of alternative signaling pathways, increased drug efflux through transporter proteins, and enhanced DNA repair capabilities. These changes allow cancer cells to survive therapeutic pressure and continue to proliferate despite treatment. In addition to tumor-intrinsic factors, non-genetic mechanisms such as epigenetic alterations, tumor heterogeneity, and influences from the tumor microenvironment also contribute to resistance. Cancer stem cells and adaptive cellular plasticity further complicate treatment response. Understanding these mechanisms has guided the development of combination therapies, next-generation inhibitors, and biomarker-driven treatment strategies aimed at preventing or overcoming resistance. Continued research in this area is critical for improving treatment durability and patient outcomes.

We welcome one-page abstracts from clinicians, researchers, and industry leaders to showcase advancements in cancer therapeutics and personalized treatment strategies

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Biomarkers play a vital role in modern oncology by enabling early cancer detection, accurate diagnosis, and risk assessment. They include genetic mutations, gene expression profiles, proteins, metabolites, and epigenetic changes that reflect the presence or behavior of cancer. Advances in molecular diagnostics, such as next-generation sequencing, liquid biopsy, and imaging biomarkers, have improved the ability to identify cancers at earlier stages and distinguish between tumor subtypes, supporting more precise clinical decision-making. In cancer therapy, biomarkers are essential for predicting treatment response, monitoring disease progression, and identifying mechanisms of resistance. Predictive biomarkers guide the selection of targeted therapies and immunotherapies, while prognostic biomarkers help assess disease outcome. The integration of biomarker-driven strategies into clinical practice supports personalized treatment approaches, reduces unnecessary toxicity, and improves therapeutic outcomes. Ongoing research continues to expand the discovery and validation of novel biomarkers to enhance precision oncology.

Submit your abstract to the International Conference on Cancer Therapeutics and participate in advancing innovation, precision medicine, and translational cancer research

Useful Links:Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Translational cancer therapeutics focuses on converting discoveries from basic cancer research into effective clinical treatments for patients. This approach bridges the gap between laboratory findings and bedside applications by integrating molecular biology, pharmacology, and clinical science. Through preclinical models, biomarker identification, and early-phase clinical trials, translational research accelerates the development of novel drugs, targeted therapies, and immunotherapies with clear clinical relevance. A key goal of translational cancer therapeutics is to improve treatment precision and patient outcomes by identifying actionable targets and predictive biomarkers. This field emphasizes rational drug design, combination strategies, and adaptive clinical trial models to optimize therapeutic efficacy and overcome resistance. By fostering collaboration between researchers, clinicians, and industry, translational cancer therapeutics plays a critical role in advancing personalized cancer care and bringing innovative treatments from the laboratory into real-world clinical practice.

The Cancer Therapeutics Conference offers a global platform for presenting original research through one-page abstract submissions from the oncology community.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Preclinical cancer models are essential tools in drug discovery, providing critical insights into tumor biology, therapeutic efficacy, and safety before clinical testing. These models include in vitro systems such as cancer cell lines and organoids, as well as in vivo models like xenografts, patient-derived xenografts (PDXs), and genetically engineered mouse models. By closely mimicking human tumor characteristics, preclinical models help researchers identify promising drug candidates, evaluate mechanisms of action, and predict treatment response. In cancer drug discovery, preclinical studies support target validation, lead optimization, and assessment of toxicity and pharmacokinetics. Advanced models incorporating tumor microenvironment components and immune interactions are improving translational relevance and success rates in clinical development. Continuous innovation in preclinical modeling and screening technologies is accelerating the discovery of effective cancer therapeutics and reducing the risk of failure in later-stage clinical trials.

We invite abstract submissions from cancer researchers, oncologists, and healthcare professionals dedicated to improving therapeutic outcomes in oncology.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Clinical trials are a cornerstone of oncology drug development, serving as the critical pathway for evaluating the safety, efficacy, and optimal use of new cancer therapies. Conducted through phased studies, clinical trials assess novel drugs, biologics, and combination treatments in carefully selected patient populations. Advances in trial design, including adaptive trials, basket trials, and biomarker-driven studies, have improved the efficiency of drug development and enabled more personalized treatment approaches. Oncology drug development increasingly integrates translational research, real-world evidence, and regulatory science to accelerate the delivery of effective therapies to patients. Close collaboration among researchers, clinicians, regulatory agencies, and industry partners is essential to address challenges such as patient recruitment, drug resistance, and safety management. Continued innovation in clinical trial methodologies is shaping the future of cancer drug development and expanding treatment options for patients worldwide.

Join the International Conference on Cancer Therapeutics by submitting a one-page abstract and sharing your contributions to advancing modern oncology

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Combination therapies and synergistic approaches are increasingly important in cancer treatment, as they target multiple pathways and mechanisms involved in tumor growth, survival, and resistance. By combining different therapeutic modalities—such as chemotherapy, targeted therapy, immunotherapy, radiation, or hormonal therapy—clinicians aim to enhance treatment efficacy, reduce the likelihood of drug resistance, and achieve more durable clinical responses. Rationally designed combinations can simultaneously inhibit complementary signaling pathways or modulate both tumor cells and the tumor microenvironment. Synergistic treatment strategies are guided by molecular profiling, biomarkers, and preclinical evidence to optimize dosing and sequencing while minimizing toxicity. Advances in systems biology and translational research have improved the identification of effective drug combinations tailored to individual patients. Ongoing clinical trials continue to evaluate novel combinations, positioning combination therapies as a key component of precision oncology and improved patient outcomes.

Researchers and clinicians are invited to submit one-page abstracts to present their work at the International Conference on Cancer Therapeutics and collaborate with global experts

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Nanomedicine and targeted drug delivery have emerged as powerful strategies to improve the effectiveness and safety of cancer therapies. By using nanoscale carriers such as liposomes, polymeric nanoparticles, dendrimers, and lipid nanoparticles, anticancer drugs can be delivered more precisely to tumor sites. These systems enhance drug stability, improve bioavailability, and reduce systemic toxicity by minimizing exposure to healthy tissues. Nanomedicine also enables controlled and sustained drug release, improving therapeutic outcomes. Targeted drug delivery systems can be engineered to recognize specific tumor markers, receptors, or microenvironmental conditions, ensuring selective uptake by cancer cells. This approach supports the delivery of chemotherapeutic agents, targeted drugs, nucleic acids, and immunotherapeutics. Continued advancements in nanotechnology, materials science, and tumor biology are expanding the potential of nanomedicine, offering promising solutions for overcoming drug resistance and advancing precision cancer therapy.

The Cancer Therapeutics Conference welcomes abstract submissions that address innovative cancer treatments, drug development, and patient-centered oncology care.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

RNA-based cancer therapeutics represent an innovative approach to treating cancer by directly targeting gene expression at the RNA level. These therapies include small interfering RNA (siRNA), microRNA (miRNA), antisense oligonucleotides, and messenger RNA (mRNA) technologies, which can silence oncogenes, restore tumor suppressor function, or stimulate immune responses. By modulating disease-driving genes with high specificity, RNA-based strategies offer significant advantages in precision and flexibility compared to traditional treatments. Recent advances in RNA stability, chemical modification, and delivery systems—particularly lipid nanoparticles—have accelerated the clinical development of RNA-based therapies in oncology. These treatments are being explored for targeting previously “undruggable” genes, overcoming drug resistance, and enhancing immunotherapy effectiveness. As research continues to improve delivery efficiency and reduce off-target effects, RNA-based cancer therapeutics are emerging as a promising and expanding pillar of personalized cancer medicine.

Submit your research for oral or poster presentation at the International Conference on Cancer Therapeutics and gain global visibility for your work.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

AI and computational oncology are transforming cancer research and clinical care by enabling the analysis of complex biological and clinical data at unprecedented scale and speed. Machine learning and deep learning algorithms are used to interpret genomic, imaging, pathology, and clinical datasets, helping identify patterns that support early diagnosis, risk stratification, and treatment selection. These technologies enhance precision oncology by integrating multi-omics data and uncovering novel biomarkers and therapeutic targets. In clinical practice and drug development, AI-driven models support treatment response prediction, clinical trial design, and real-time decision-making. Computational oncology also accelerates drug discovery, optimizes combination therapies, and improves outcome prediction through digital pathology and radiomics. As AI tools continue to evolve, they hold great potential to improve accuracy, efficiency, and personalization in cancer care while supporting clinicians and researchers in delivering better patient outcomes.

We encourage oncologists, translational scientists, and industry professionals to submit one-page abstracts and contribute to impactful discussions at the Cancer Therapeutics Conference

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Cancer pharmacology focuses on understanding how anticancer drugs interact with biological systems, including their absorption, distribution, metabolism, mechanism of action, and elimination. This knowledge is essential for optimizing drug dosing, scheduling, and combination strategies to maximize therapeutic benefit while minimizing harm. Advances in pharmacogenomics and precision dosing have further improved the ability to tailor treatments based on individual patient characteristics and tumor biology. Toxicity management is a critical component of cancer therapy, as many anticancer agents can cause significant adverse effects that impact patient quality of life and treatment adherence. Effective toxicity management involves early detection, supportive care, dose modifications, and patient education to prevent or reduce treatment-related complications. Integrating pharmacological insights with proactive toxicity monitoring enhances treatment safety, supports long-term therapy, and contributes to improved clinical outcomes in oncology.

The International Conference on Cancer Therapeutics invites researchers and clinicians to submit abstracts highlighting advances in targeted therapy, immunotherapy, and precision oncology.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit| Cancer Pharmacology conferences | Toxicity Management

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Precision radiation therapy has advanced significantly with the integration of imaging, treatment planning, and delivery technologies that allow highly accurate targeting of tumors while sparing surrounding healthy tissues. Techniques such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiotherapy (SBRT), and proton therapy enable precise dose delivery based on tumor size, location, and motion. These approaches improve local tumor control, reduce treatment-related toxicity, and support personalized radiation strategies. Radiopharmaceutical therapies combine targeted radiation with molecular specificity by delivering radioactive isotopes directly to cancer cells through ligands, antibodies, or peptides. This approach enables both diagnostic imaging and therapeutic intervention, often referred to as theranostics. Radiopharmaceuticals have shown promising results in cancers such as prostate and neuroendocrine tumors. Continued advancements in radionuclide development, targeting agents, and combination strategies are expanding the role of precision radiation and radiopharmaceutical therapies in modern cancer care.

Share your scientific contributions by submitting a one-page abstract to the Cancer Therapeutics Conference and engage with leaders shaping the future of cancer care.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit| Precision Radiation conference | Radiopharmaceutical Therapies workshop

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Pediatric and rare cancer therapeutics address the unique biological, clinical, and developmental challenges associated with treating cancers that occur in children and less common adult malignancies. These cancers often differ significantly from adult cancers in their genetic drivers and disease behavior, requiring specialized therapeutic approaches. Advances in molecular profiling and precision medicine have improved the identification of actionable targets, enabling the development of more effective and less toxic treatments tailored to young patients and rare cancer populations. Drug development for pediatric and rare cancers faces challenges such as limited patient populations, fewer clinical trials, and a lack of targeted therapies. To overcome these barriers, collaborative research networks, adaptive clinical trial designs, and regulatory incentives have been established to accelerate therapeutic innovation. Ongoing efforts to integrate targeted therapy, immunotherapy, and supportive care aim to improve survival outcomes while minimizing long-term treatment-related effects, ultimately enhancing quality of life for patients with pediatric and rare cancers.

We welcome abstract submissions from academia, clinics, and industry to the International Conference on Cancer Therapeutics, fostering collaboration and innovation in oncology

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Pediatric conference | Rare Cancer Therapeutics workshop

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Metastasis is the leading cause of cancer-related mortality and involves a complex, multi-step biological process in which cancer cells spread from the primary tumor to distant organs. This process includes local invasion, intravasation into blood or lymphatic vessels, survival in circulation, extravasation, and colonization of secondary sites. Molecular mechanisms such as epithelial–mesenchymal transition (EMT), tumor cell plasticity, interactions with the tumor microenvironment, and organ-specific niche formation play critical roles in metastatic progression. Therapeutic strategies targeting metastasis aim to interrupt these biological processes and prevent tumor dissemination or growth at secondary sites. Approaches include inhibiting key signaling pathways, targeting cell adhesion and migration, modulating the tumor microenvironment, and enhancing immune-mediated clearance of metastatic cells. Advances in molecular profiling and translational research are enabling the development of targeted and combination therapies designed to suppress metastatic spread, improve treatment durability, and enhance survival outcomes in patients with advanced cancer.

The Cancer Therapeutics Conference invites one-page abstracts showcasing innovative research, clinical advances, and translational approaches in cancer treatment

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop| International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Metastasis Biology Conferences | Therapeutic Strategies

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Cancer stem cells (CSCs) are a subpopulation of tumor cells with self-renewal and differentiation capabilities, believed to play a central role in tumor initiation, progression, and recurrence. These cells can survive conventional therapies and contribute to tumor heterogeneity, metastasis, and treatment resistance. CSCs are regulated by key signaling pathways such as Wnt/β-catenin, Notch, and Hedgehog, as well as interactions with the tumor microenvironment that support their maintenance and survival. The persistence of cancer stem cells is strongly associated with disease progression and poor clinical outcomes. Therapeutic strategies targeting CSC-specific pathways, surface markers, and metabolic dependencies are being actively investigated to overcome resistance and prevent relapse. Combining CSC-targeted therapies with conventional treatments and immunotherapy holds promise for achieving more durable responses and improving long-term cancer control.

Oncologists, researchers, and healthcare professionals are invited to present original research at the Cancer Therapeutics Conference through one-page abstract submissions.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Cancer Stem Cells conference | Disease Progression workshop

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Tumor metabolism is characterized by profound alterations that support rapid cancer cell growth, survival, and adaptation to hostile environments. Cancer cells often reprogram metabolic pathways to meet increased energy and biosynthetic demands, a phenomenon exemplified by the Warburg effect, where cells preferentially rely on glycolysis even in the presence of oxygen. In addition to glucose metabolism, alterations in lipid, amino acid, and mitochondrial metabolism contribute to tumor progression, immune evasion, and therapeutic resistance. Metabolic targeting aims to exploit these cancer-specific metabolic dependencies to inhibit tumor growth while sparing normal cells. Therapeutic strategies include targeting key metabolic enzymes, nutrient transporters, and metabolic signaling pathways, as well as combining metabolic inhibitors with chemotherapy, targeted therapy, or immunotherapy. Advances in metabolomics and systems biology are improving the identification of actionable metabolic vulnerabilities, positioning metabolic targeting as a promising approach in precision cancer therapy.

Submit your one-page abstract to the International Conference on Cancer Therapeutics and be part of a global platform advancing novel cancer treatment strategies and precision oncology.

Relevant Conferences: World Cancer Congress| Oncology 2026 Conference| Cancer Research and Therapy conferences | Global Oncology summit| Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Tumor Metabolism conferences | Metabolic Targeting workshop

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Liquid biopsy and molecular diagnostics have revolutionized cancer detection and monitoring by enabling non-invasive analysis of tumor-derived material circulating in body fluids such as blood. These approaches detect circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), RNA, exosomes, and other biomarkers that reflect the genetic and molecular landscape of tumors. Liquid biopsies provide real-time insights into tumor heterogeneity, disease progression, and minimal residual disease, supporting earlier diagnosis and more precise clinical decision-making. In cancer therapeutics, liquid biopsy plays a crucial role in guiding treatment selection, monitoring therapeutic response, and identifying emerging resistance mechanisms. When integrated with advanced molecular diagnostic technologies such as next-generation sequencing and digital PCR, liquid biopsies enable dynamic and personalized treatment strategies. Ongoing advancements in sensitivity, standardization, and data interpretation are expanding their clinical utility, making liquid biopsy a key component of precision oncology and personalized cancer care.

We invite abstract submissions from oncologists, cancer researchers, and pharmaceutical scientists to present cutting-edge findings at the Cancer Therapeutics Conference and engage with an international audience

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Liquid Biopsy workshop | Molecular Diagnostics seminars

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Regulatory approval of cancer drugs involves complex and rigorous processes designed to ensure safety, efficacy, and quality while addressing urgent patient needs. Challenges arise from the biological complexity of cancer, heterogeneous patient populations, and rapidly evolving therapeutic modalities such as gene therapy, immunotherapy, and personalized medicine. Demonstrating meaningful clinical benefit, selecting appropriate endpoints, and managing accelerated approval pathways while maintaining robust evidence standards remain key regulatory hurdles. Additional challenges include harmonizing global regulatory requirements, managing post-marketing safety surveillance, and integrating real-world evidence into regulatory decision-making. Adaptive trial designs, biomarker-driven studies, and companion diagnostics add further complexity to the approval process. Continued collaboration among regulators, industry, clinicians, and researchers is essential to streamline approval pathways, reduce development timelines, and ensure timely patient access to innovative and effective cancer therapies.

The International Conference on Cancer Therapeutics welcomes one-page abstract submissions from scientists, clinicians, and healthcare professionals working in oncology and translational cancer research.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop| International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Regulatory Challenges workshop | Cancer Drug Approval

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Industry–academia partnerships play a critical role in advancing oncology innovation by combining academic scientific expertise with industry resources, infrastructure, and development capabilities. Academic institutions contribute deep biological insights, novel discoveries, and access to early-stage research, while industry partners provide drug development expertise, funding, regulatory experience, and commercialization pathways. These collaborations accelerate the translation of basic research into viable cancer therapies, diagnostics, and technologies with real-world clinical impact. Such partnerships foster interdisciplinary collaboration, support large-scale clinical trials, and promote the sharing of data, technologies, and intellectual property. By aligning scientific discovery with patient needs and market realities, industry–academia collaborations help overcome development challenges, reduce research timelines, and drive innovation in precision oncology, immunotherapy, and personalized medicine. Strengthening these partnerships is essential for sustaining progress and delivering next-generation cancer treatments to patients worldwide.

Researchers, clinicians, and oncology professionals are encouraged to submit one-page abstracts to the Cancer Therapeutics Conference. Join global experts in shaping the future of innovative and personalized cancer treatment.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Industry-Academia Partnerships workshop | Oncology Innovation

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Emerging therapeutic strategies in oncology are reshaping cancer care by focusing on precision, personalization, and novel mechanisms of action. Advances in immunotherapy, cell and gene therapies, RNA-based treatments, and targeted drug delivery are expanding treatment options beyond conventional approaches. Innovative strategies such as bispecific antibodies, antibody–drug conjugates, tumor-agnostic therapies, and combination regimens are enabling more effective targeting of complex and heterogeneous cancers. Future oncology trends emphasize data-driven and patient-centered care, integrating artificial intelligence, multi-omics profiling, and real-world evidence to guide treatment decisions. Adaptive clinical trials, early detection technologies, and preventive strategies are also gaining importance. As scientific discovery and technology continue to evolve, these emerging approaches hold promise for improving survival, reducing toxicity, and transforming cancer into a more manageable and treatable disease.

We invite oncologists, researchers, clinicians, and industry experts to submit one-page abstracts for presentation at the International Conference on Cancer Therapeutics. Share your research, connect with global leaders, and contribute to advancing precision cancer care.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | Internationa l Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Cancer therapeutic workshop | Emerging therapeutic strategies summit | future oncology trends

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Join us at the International Conference on Cancer Therapeutics by submitting a one-page abstract and contributing to advancements in precision-driven cancer treatment.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

We invite abstract submissions that highlight novel therapeutic strategies and translational research at the International Conference on Cancer Therapeutics

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Present your research at the Cancer Therapeutics Conference by submitting a one-page abstract and engaging with international oncology leaders.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Researchers, clinicians, and pharmaceutical experts are invited to submit one-page abstracts for presentation at the International Conference on Cancer Therapeutics.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

The Cancer Therapeutics Conference welcomes abstract submissions focused on targeted therapies, immuno-oncology, and next-generation cancer treatments.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Submit your abstract to the Internati onal Conference on Cancer Therapeutics and join global discussions driving innovation in cancer care.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

We invite professionals across the oncology spectrum to submit one-page abstracts and contribute to shaping the future of cancer therapeutics.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

The Cancer Therapeutics Conference invites abstracts that reflect cutting-edge science, clinical excellence, and translational impact in cancer treatment.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Share your research findings by submitting a one-page abstract to the International Conference on Cancer Therapeutics and connect with a global oncology network

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Oncologists and cancer researchers are encouraged to submit one-page abstracts and engage in meaningful scientific exchange at the Cancer Therapeutics Conference.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

cancer patients.

The International Conference on Cancer Therapeutics invites the submission of abstracts highlighting breakthrough discoveries and clinical innovations in oncology.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

We welcome one-page abstracts from clinicians, researchers, and industry leaders to showcase advancements in cancer therapeutics and personalized treatment strategies

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Submit your abstract to the International Conference on Cancer Therapeutics and participate in advancing innovation, precision medicine, and translational cancer research

Useful Links:Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

The Cancer Therapeutics Conference offers a global platform for presenting original research through one-page abstract submissions from the oncology community.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

We invite abstract submissions from cancer researchers, oncologists, and healthcare professionals dedicated to improving therapeutic outcomes in oncology.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Join the International Conference on Cancer Therapeutics by submitting a one-page abstract and sharing your contributions to advancing modern oncology

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Researchers and clinicians are invited to submit one-page abstracts to present their work at the International Conference on Cancer Therapeutics and collaborate with global experts

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

The Cancer Therapeutics Conference welcomes abstract submissions that address innovative cancer treatments, drug development, and patient-centered oncology care.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Submit your research for oral or poster presentation at the International Conference on Cancer Therapeutics and gain global visibility for your work.

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

We encourage oncologists, translational scientists, and industry professionals to submit one-page abstracts and contribute to impactful discussions at the Cancer Therapeutics Conference

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

The International Conference on Cancer Therapeutics invites researchers and clinicians to submit abstracts highlighting advances in targeted therapy, immunotherapy, and precision oncology.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit| Cancer Pharmacology conferences | Toxicity Management

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Share your scientific contributions by submitting a one-page abstract to the Cancer Therapeutics Conference and engage with leaders shaping the future of cancer care.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit| Precision Radiation conference | Radiopharmaceutical Therapies workshop

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

We welcome abstract submissions from academia, clinics, and industry to the International Conference on Cancer Therapeutics, fostering collaboration and innovation in oncology

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Pediatric conference | Rare Cancer Therapeutics workshop

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

The Cancer Therapeutics Conference invites one-page abstracts showcasing innovative research, clinical advances, and translational approaches in cancer treatment

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop| International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Metastasis Biology Conferences | Therapeutic Strategies

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Oncologists, researchers, and healthcare professionals are invited to present original research at the Cancer Therapeutics Conference through one-page abstract submissions.

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Cancer Stem Cells conference | Disease Progression workshop

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Submit your one-page abstract to the International Conference on Cancer Therapeutics and be part of a global platform advancing novel cancer treatment strategies and precision oncology.

Relevant Conferences: World Cancer Congress| Oncology 2026 Conference| Cancer Research and Therapy conferences | Global Oncology summit| Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Tumor Metabolism conferences | Metabolic Targeting workshop

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Liquid Biopsy workshop | Molecular Diagnostics seminars

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop| International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Regulatory Challenges workshop | Cancer Drug Approval

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | International Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Industry-Academia Partnerships workshop | Oncology Innovation

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Relevant Conferences: World Cancer Congress | Oncology 2026 Conference | Cancer Research and Therapy conferences | Global Oncology summit | Experts Meet on Cancer Research & Therapy meeting | International Conference on Cancer Research and Treatment workshop | Internationa l Virtual Conference on Cancer Research and Oncology seminar | International Conference on Cancer Science and Therapy event | International Conference of Global Cancer Consortium congress | Global Summit on Cancer Research and Novel Drug Development conference | International Cancer & Immuno-Oncology Conference | Cancer Science and Therapeutic Innovations meetings | Precision in Clinical Trials Oncology Summit | Cancer therapeutic workshop | Emerging therapeutic strategies summit | future oncology trends

Useful Links: Brochure Download | Abstract Submission | Register Now

Like, Share and follow our social media pages and stay updated: LinkedIn | Facebook | Twitter | Instagram | YouTube

Scientific Sessions

Filter by Day

Session 1: Molecular Targets in Cancer Therapy

Session 2: Precision Oncology and Personalized Cancer Treatment

Session 3: Targeted Small-Molecule Cancer Therapeutics

Session 4: Monoclonal Antibodies and Antibody-Drug Conjugates

Session 5: Immunotherapy and Immune Checkpoint Inhibitors

Session 6: Cancer Vaccines and Cellular Immunotherapies

Session 7: CAR-T and Advanced Cell-Based Therapies

Session 8: Gene Therapy and Genome Editing in Cancer

Session 9: Epigenetic Targets and Chromatin Remodeling

Session 10: Signal Transduction Pathways in Cancer

Session 11: Tumor Microenvironment and Therapeutic Resistance

Session 12: Mechanisms of Drug Resistance in Cancer

Session 13: Biomarkers for Cancer Diagnosis and Therapy

Session 14: Translational Cancer Therapeutics

Session 15: Preclinical Cancer Models and Drug Discovery

Session 16: Clinical Trials and Oncology Drug Development

Session 17: Combination Therapies and Synergistic Approaches

Session 18: Nanomedicine and Targeted Drug Delivery

Session 19: RNA-Based Cancer Therapeutics

Session 20: AI and Computational Oncology

Session 21: Cancer Pharmacology and Toxicity Management

Session 22: Precision Radiation and Radiopharmaceutical Therapies

Session 23: Pediatric and Rare Cancer Therapeutics

Session 24: Metastasis Biology and Therapeutic Strategies

Session 25: Cancer Stem Cells and Disease Progression

Session 26: Tumor Metabolism and Metabolic Targeting

Session 27: Liquid Biopsy and Molecular Diagnostics

Session 28: Regulatory Challenges in Cancer Drug Approval

Session 29: Industry-Academia Partnerships in Oncology Innovation

Session 30: Emerging Therapeutic Strategies and Future Oncology Trends

Session 1: Molecular Targets in Cancer Therapy

Session 2: Precision Oncology and Personalized Cancer Treatment

Session 3: Targeted Small-Molecule Cancer Therapeutics

Session 4: Monoclonal Antibodies and Antibody-Drug Conjugates

Session 5: Immunotherapy and Immune Checkpoint Inhibitors

Session 6: Cancer Vaccines and Cellular Immunotherapies

Session 7: CAR-T and Advanced Cell-Based Therapies

Session 8: Gene Therapy and Genome Editing in Cancer

Session 9: Epigenetic Targets and Chromatin Remodeling

Session 10: Signal Transduction Pathways in Cancer

Session 11: Tumor Microenvironment and Therapeutic Resistance

Session 12: Mechanisms of Drug Resistance in Cancer

Session 13: Biomarkers for Cancer Diagnosis and Therapy

Session 14: Translational Cancer Therapeutics

Session 15: Preclinical Cancer Models and Drug Discovery

Session 16: Clinical Trials and Oncology Drug Development

Session 17: Combination Therapies and Synergistic Approaches

Session 18: Nanomedicine and Targeted Drug Delivery

Session 19: RNA-Based Cancer Therapeutics

Session 20: AI and Computational Oncology

Session 21: Cancer Pharmacology and Toxicity Management

Session 22: Precision Radiation and Radiopharmaceutical Therapies

Session 23: Pediatric and Rare Cancer Therapeutics

Session 24: Metastasis Biology and Therapeutic Strategies

Session 25: Cancer Stem Cells and Disease Progression

Session 26: Tumor Metabolism and Metabolic Targeting

Session 27: Liquid Biopsy and Molecular Diagnostics

Session 28: Regulatory Challenges in Cancer Drug Approval

Session 29: Industry-Academia Partnerships in Oncology Innovation

Session 30: Emerging Therapeutic Strategies and Future Oncology Trends